1/44
Vocabulary flashcards covering fundamental concepts, mechanisms, characteristics, and terminology of cancer biology and pathophysiology from Week 3 notes.
Cancer
Uncontrolled proliferation of cells.
Neoplasm
"New growth"; an abnormal, irreversible cellular development.
Tumour
A mass resulting from abnormal cell proliferation.
Malignant
Cancerous, invasive, and destructive cellular development.
Benign
Non-malignant growth that generally remains localised.
Carcinogenesis
The origin and development of cancerous neoplasms.
Cell Proliferation
The process of increasing cell numbers through the generation of new daughter cells.
Stem Cells
Highly undifferentiated reserve cells capable of dividing when needed and possessing self-renewal and potency.
Progenitor / Parent Cells
Cells that continue dividing and reproducing, such as blood and skin cells.
Well-Differentiated Cells
Highly specialised cells that rarely divide, such as neurons, cardiac, and skeletal muscle cells.
Cell Differentiation
The process where proliferating cells become progressively more specialised in structure, function, and life expectancy.
Self-Renewal
The ability of stem cells to produce more stem cells.
Potency
The ability of stem cells to develop into different cell types.
Parenchymal Cells
Functional cells of a tissue or organ.
Stromal Cells
Supportive cells of a tissue or organ.
Labile Cells
Actively dividing cells, such as epithelial and blood cells, that are most prone to neoplasms.
Permanent Cells
Cells that generally do not divide (e.g., neurons and mature cardiac cells), making them less prone to neoplasm development.
Acquired Mutations
Genetic mutations occurring after conception due to environmental exposure or spontaneous mutations.
Inherited / Germline Mutations
Genetic mutations present before birth that can be passed to offspring.
Telomeres
Protective caps made of repetitive DNA sequences at the ends of chromosomes that shorten with normal cell division.
Mutator Genes
Genes responsible for repairing DNA and protecting the genome.
Proto-Oncogenes
Normal genes involved in regulating protein production, cell growth, and cell function.
Oncogenes
Mutated or activated cancer-promoting genes that promote uncontrolled cell growth and inhibit cell death.
Tumour Suppressor Genes
Genes that regulate how quickly cells divide and die, such as p53, Retinoblastoma (Rb), and BCL-2.
Carcinogen
A known cancer-causing agent.
Direct Carcinogens
Carcinogens that directly modify DNA.
Indirect Carcinogens
Carcinogens that contribute to cancer through immunosuppression, chronic inflammation, or interactions with other factors.
Initiation
The first stage of carcinogenesis where an initiator causes a genetic mutation in a cell.
Promotion
The second stage of carcinogenesis where a promoter stimulates the expansion and growth of mutated cells.
Progression
The stage of carcinogenesis where cancer growth becomes autonomous and independent of the promoter.
Autonomy
Unregulated cellular proliferation.
Anaplasia
Loss of cellular differentiation, leading to loss of normal cell function.
Local Spread
Cancer growth that remains within the tissue of origin.
Direct Extension
Movement of tumour cells into adjacent tissues or organs.
Seeding
Implantation of cancer cells within body cavities.
Metastasis
Spread of cancer to distant sites, with embolism being the main mechanism.
Tropism
The affinity of a primary tumour for a particular distant metastatic site.
Carcinoma in Situ
A carcinoma that remains confined to the epithelium and has not penetrated the basement membrane.
TNM Staging
System used for solid tumours to describe extent of spread: Tumour size/extent (T), Lymph node involvement (N), and Distant metastasis (M).
Cancer Grading
Determination of the level of anaplasia or loss of differentiation in a tumour.
Prognosis
The expected course or outcome of a disease.
5-Year Survival Rate
The percentage of people who are alive 5 years after diagnosis.
Paraneoplastic Syndromes
Hormonal, neurological, haematological, or chemical disturbances caused by cancer but not directly due to invasion of the primary tumour.
Tumour Markers
Substances produced by the tumour or by unaffected cells responding to it, used for monitoring, screening, or diagnosis.
Palliation
Cancer treatment strategy aimed at reducing symptoms without curing the cancer.